These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30740300)

  • 1. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.
    Sato Y; Tanaka Y; Hino M; Seike M; Gemma A
    Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report.
    Furubayashi N; Negishi T; Uozumi T; Takamatsu D; Shiraishi K; Hirose D; Nakamura M
    Mol Clin Oncol; 2019 Feb; 10(2):304-308. PubMed ID: 30680212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report.
    Iesaka H; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Abe T; Shinohara N; Atsumi T
    Medicine (Baltimore); 2023 Dec; 102(51):e36664. PubMed ID: 38134115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report.
    Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M
    Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
    Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
    Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S; Leiter A; Galsky M; Gallagher EJ
    J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Cases of Atezolizumab-Induced Hypophysitis.
    Kanie K; Iguchi G; Bando H; Fujita Y; Odake Y; Yoshida K; Matsumoto R; Fukuoka H; Ogawa W; Takahashi Y
    J Endocr Soc; 2018 Jan; 2(1):91-95. PubMed ID: 29362727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report.
    Marshall S; Kizuki A; Kitaoji T; Imada H; Kato H; Hosoda M; Ishikawa M; Sakura H
    Case Rep Oncol; 2020; 13(3):1185-1190. PubMed ID: 33173483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency.
    Katakura Y; Kimura T; Kusano T; Tatsumi F; Iwamoto Y; Sanada J; Fushimi Y; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
    Front Endocrinol (Lausanne); 2021; 12():722586. PubMed ID: 34712202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Isolated ACTH Deficiency Induced by Nivolumab in a Patient with Gastric Cancer Metastasis of the Peritoneum].
    Mashita N; Otake K; Nonogaki A; Saito H; Nakamura M; Yamanaka M; Tobinaga J; Ishigure K
    Gan To Kagaku Ryoho; 2019 Dec; 46(12):1879-1882. PubMed ID: 31879407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated adrenocorticotropic hormone deficiency induced by nivolumab treatment for advanced gastric cancer.
    Namikawa T; Shimizu S; Yokota K; Tanioka N; Fukudome I; Munekage M; Uemura S; Maeda H; Kitagawa H; Hanazaki K
    Clin J Gastroenterol; 2021 Aug; 14(4):988-993. PubMed ID: 33715100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathy.
    Okahata S; Sakamoto K; Mitsumatsu T; Kondo Y; Noso S; Ikegami H; Shiba T
    Endocr J; 2019 Apr; 66(4):295-300. PubMed ID: 30814440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.
    Zeng MF; Chen LL; Ye HY; Gong W; Zhou LN; Li YM; Zhao XL
    Medicine (Baltimore); 2017 Nov; 96(44):e8426. PubMed ID: 29095280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nivolumab Induced Adrenal Insufficiency: Rare Side-effect of a New Anti-cancer Therapy - Immune-checkpoint Inhibitors.
    Rai M; Go M
    Cureus; 2020 Apr; 12(4):e7625. PubMed ID: 32399358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
    Hashinokuchi A; Haro A; Minagawa R; Haruta Y; Kawano H; Suehiro T; Sugimachi K
    Cancer Diagn Progn; 2023; 3(4):498-503. PubMed ID: 37405219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.
    Ariyasu H; Inaba H; Ota T; Yamaoka H; Furukawa Y; Iwakura H; Doi N; Yamamoto Y; Akamizu T
    In Vivo; 2018; 32(2):345-351. PubMed ID: 29475919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.